Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqGS - Nasdaq Real Time Price USD

Bioventus Inc. (BVS)

Compare
9.15
-0.36
(-3.79%)
At close: April 3 at 4:00:01 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
573,280
573,280
512,345
512,117
430,898
Cost of Revenue
185,054
185,054
184,152
181,037
128,192
Gross Profit
388,226
388,226
328,193
331,080
302,706
Operating Expense
362,185
362,185
326,167
365,736
281,655
Operating Income
26,041
26,041
2,026
-34,656
21,051
Net Non Operating Interest Income Expense
-38,792
-38,792
-40,676
-12,021
-1,112
Other Income Expense
-36,375
-36,375
-82,461
-142,348
-10,451
Pretax Income
-49,126
-49,126
-121,111
-189,025
9,488
Tax Provision
-5,293
-5,293
85
-44,374
-1,966
Net Income Common Stockholders
-33,542
-33,542
-156,230
-158,704
19,375
Diluted NI Available to Com Stockholders
-33,542
-33,542
-156,230
-158,704
19,375
Basic EPS
-0.52
--
-2.49
-2.59
-0.15
Diluted EPS
-0.52
--
-2.49
-2.59
-0.15
Basic Average Shares
64,547.47
--
62,647.55
61,389.11
45,472.48
Diluted Average Shares
64,547.47
--
62,647.55
61,389.11
45,472.48
Total Operating Income as Reported
-11,979
-11,979
-81,725
-167,234
12,061
Total Expenses
547,239
547,239
510,319
546,773
409,847
Net Income from Continuing & Discontinued Operation
-33,542
-33,542
-156,230
-158,704
19,375
Normalized Income
381.60
381.60
-15,637.71
11,458.17
27,913.58
Interest Expense
38,792
38,792
40,676
12,021
1,112
Net Interest Income
-38,792
-38,792
-40,676
-12,021
-1,112
EBIT
-10,334
-10,334
-80,435
-177,004
10,600
EBITDA
39,221
39,221
-23,070
-121,606
45,475
Reconciled Cost of Revenue
143,151
143,151
135,629
135,387
101,680
Reconciled Depreciation
49,555
49,555
57,365
55,398
34,875
Net Income from Continuing Operation Net Minority Interest
-33,542
-33,542
-81,801
-89,964
21,243
Total Unusual Items Excluding Goodwill
-38,020
-38,020
-83,751
-132,578
-8,990
Total Unusual Items
-38,020
-38,020
-83,751
-132,578
-8,990
Normalized EBITDA
77,241
77,241
60,681
10,972
54,465
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-4,096.40
-4,096.40
-17,587.71
-31,155.83
-2,319.42
12/31/2021 - 2/11/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

OFIX Orthofix Medical Inc.
15.54
-4.66%
 
FNA Paragon 28, Inc.
13.07
-0.08%
 
XTNT Xtant Medical Holdings, Inc.
0.4701
+0.02%
 
AVNS Avanos Medical, Inc.
14.03
-3.37%
 
ELUT Elutia Inc.
2.9100
+5.05%
 
APYX Apyx Medical Corporation
1.1600
-5.69%
 
TMCI Treace Medical Concepts, Inc.
7.83
-5.89%
 
AORT Artivion, Inc.
24.14
-3.63%
 
LUNG Pulmonx Corporation
6.76
-0.88%
 
TLSI TriSalus Life Sciences, Inc.
5.22
-5.61%